![]() |
Member Log In Register Forgot pw? |
|
Success with Heart Failure Symposium: Perspectives from the Big Apple
|
On-site registration will be available. |
Robert E. Michler, MD James B. Young, MD | |
Cardiothoracic | |
October 09, 2009 October 09, 2009 7:00 AM Harvard Club of New York, 27 West 44th Street, New York, NY 10036 718-920-6674 npiacent@montefiore. org and chrclark@montefiore. |
|
This activity is intended for physicians and other health care professional involved in the care and treatment of heart failure patients. |
|
Over 500,000 new cases of congestive heart failure are diagnosed in the United States each year. Medical and surgical therapies for heart failure are continuously evolving and offer many options to extend and improve life for patients. |
|
After participating in this program, the participants should be able to: Identify emerging mechanical assist devices Discuss NYHA Class III patients who may benefit from advanced cardiac therapies Recognize the relevant parameters of left ventricular geometry and function and identify patients that may benefit from surgical ventricular reconstruction Recognize the deeper consequences of long term anti-coagulation and the incremental risk of stroke while patients are on anti-coagulation Distinguish the risks and benefits of percutaneous intervention versus surgical procedures in the treatment of atrial filbrillation |
|
7
Albert Einstein College of Medicine is accredited by the Accreditation | |
The “Conflict of Interest Disclosure Policy” of Albert Einstein College of Medicine requires that faculty participating in any CME activity disclose to the audience any relationship(s) with a pharmaceutical or equipment company. Any presenter whose disclosed relationships prove to create a conflict of interest, with regard to their contribution to the activity, will not be permited to present. Albert Einstein College of Medicine also requires that faculty participating in any CME activitydisclose to the audience when discussin ant unlabeled or investigationaluse of any coomercial products or device, not yet approved for use in the Untied States. |
|